IP Library Granted Patent US 9,018,412
Granted Patent B2
US 9,018,412 · App. 13/898,126 · Granted Apr 28, 2015

α-keto alkylperacids and methods for producing and using the same

Inventors: Edwin D. Neas (Nunn, CO); John D. Skinner (Fort Collins, CO)
Assignee: CHD Bioscience, Inc.
A01N37/42C07C409/24
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,018,412
App. No.
13/898,126
Granted
Apr 28, 2015
Kind
B2
Abstract

The present invention provides α-keto alkylperacids and methods for producing and using the same. In particular, α-keto alkylperacids are useful as antimicrobial agents.

Claims (20)

1. A product for reducing the number of pathogens on a health care hard surface comprising a peroxy α-ketocarboxylic acid.

2. The product of claim 1 , wherein the peroxy α-ketocarboxylic acid is selected from the group consisting of peroxy pyruvic acid, peroxy α-ketobutyric acid, peroxy α-ketovaleric acid, or combination thereof.

3. The product of claim 1 , wherein the product further comprises an antimicrobial agent.

4. The product of claim 1 , wherein the product further comprises an antifungal agent.

5. The product of claim 1 , wherein the product further comprises hydrogen peroxide.

6. The product of claim 1 , wherein the product further comprises an alcohol.

7. The product of claim 1 , wherein the product further comprises a surfactant.

8. The product of claim 1 , wherein the product further comprises an organic acid.

9. The product of claim 1 , wherein the product is in the form of a wipe.

10. The product of claim 1 , wherein the product is in the form of a spray.

11. The product of claim 1 , wherein the product is in the form of a liquid.

12. The product of claim 1 , wherein the product is in the form of a gel.

13. A method for reducing the number of pathogens on a health care hard surface comprising contacting the health care hard surface with a composition comprising an effective amount of a peroxy α-ketocarboxylic acid.

14. The method of claim 13 , wherein the peroxy α-ketocarboxylic acid is selected from a group consisting of peroxy pyruvic acid, peroxy α-ketobutyric acid, peroxy α-ketovaleric acid, or combination thereof.

15. The method of claim 13 , wherein the health care hard surface is located in a hospital.

16. The method of claim 13 , wherein the health care hard surface is located in a rehabilitation facility.

17. The method of claim 13 , wherein the health care hard surface is located in an assisted living facility.

18. The method of claim 13 , wherein the composition penetrates into cracks and crevices of the substrate.

19. The method of claim 13 , wherein the pathogen is selected from a group consisting of bacterial spores, mycobacteria, enveloped/non-enveloped viruses, gram-negative bacteria, gram-positive bacteria, fungi, prions, or a combination thereof.

20. The method of claim 13 , further comprising allowing the substrate to dry.

Assignments (3)
CHANGE OF NAME Recorded Jan 31, 2022
From: CHD BIOSCIENCE, INC.
To: ARMIS BIOPHARMA, INC.
Reel/Frame 058834/0571 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 24, 2013
From: NEAS, EDWIN D.; SKINNER, JOHN D.
To: CHATA BIOSYSTEMS, INC.
Reel/Frame 030481/0711 →
CHANGE OF NAME Recorded May 24, 2013
From: CHATA BIOSYSTEMS, INC.
To: CHD BIOSCIENCE, INC.
Reel/Frame 030490/0348 →
Continuity (4)
Continuation 12760940 · Apr 15, 2010
Continuation In Part 12618605 · Nov 13, 2009
Provisional Application 61199944 · Nov 20, 2008
Related Publication 20130251820A1 · Sep 26, 2013